Journal
PHARMACEUTICALS
Volume 12, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/ph12040152
Keywords
diabetes mellitus; metabolic syndrome; glucose-lowering agents; sugar-lowering oils; phytotherapy
Categories
Funding
- Portuguese Science and Technology Foundation (FCT/MCT)
- European Funds (PRODER/COMPETE) [M-ERA-NET/0004/2015-PAIRED, UID/AGR/04033/2019]
- FEDER, under the Partnership Agreement PT2020
- Institute of Nanoscience and Nanotechnology under the project ART(2018)
Ask authors/readers for more resources
Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia together with disturbances in the metabolism of carbohydrates, proteins and fat, which in general results from an insulin availability and need imbalance. In a great number of patients, marketed anti-glycemic agents have shown poor effectiveness in maintaining a long-term glycemic control, thus being associated with severe adverse effects and leading to an emerging interest in natural compounds (e.g., essential oils and other secondary plant metabolites, namely, flavonoid-rich compounds) as a novel approach for prevention, management and/or treatment of either non-insulin-dependent diabetes mellitus (T2DM, type 2 DM) and/or Metabolic Syndrome (MS). In this review, some of these promising glucose-lowering agents will be comprehensively discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available